CELC
Celcuity Inc
NASDAQ · Biotechnology
$106.75
+2.47 (+2.37%)
Performance
1D
—
1W
-4.12%
1M
+2.14%
3M
+34.84%
6M
+103.84%
1Y
+799.33%
YTD
+6.17%
Open$106.12
Previous Close$104.28
Day High$109.50
Day Low$104.61
52W High$120.32
52W Low$7.58
Volume638.0K
Avg Volume962.2K
Market Cap4.94B
P/E Ratio—
EPS$-3.67
SectorBiotechnology
Volume Analysis
0.66x average volume
Technical Indicators
SMA 50
$104.84
Above
SMA 200
$55.32
Above
RSI (14)
49.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
-76.1% upside
Current
$106.75
$106.75
Target
$25.56
$25.56
$16.07
$25.56 avg
$38.64
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 856.50M | 842.65M | 828.36M |
| Net Income | -244,490,059 | -213,463,076 | -182,555,570 |
| Profit Margin | -28.6% | -25.3% | -22.0% |
| EBITDA | -292,781,484 | -259,398,727 | -297,826,578 |
| Free Cash Flow | -124,649,561 | -156,876,378 | -179,431,543 |
| Rev Growth | +6.2% | -3.6% | +12.6% |
| Debt/Equity | 1.11 | 1.11 | 1.34 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |